Current Neuro-Oncology

Volume 27 Number 1
10 January 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 1, 10 January

Chen CH, Hsu SY, Yu WJ, Chiang CS, Yu CF.
Distinct roles of small extracellular vesicles from resident and infiltrating macrophages on glioma growth and mobility.
J Cancer. 2025 Jan 1;16(3):969-981. doi: 10.7150/jca.103595. PMID: 39781357. Laboratory investigation. ˍ

Gao J, Gu D, Yang K, Zhang J, Lin Q, Yuan W, Zhu X, Dixit D, Gimple RC, You H, Zhang Q, Shi Z, Fan X, Wu Q, Lu C, Cheng Z, Li D, Zhao L, Xue B, Zhu Z, Zhu Z, Yang H, Zhao N, Gao W, Lu Y, Shao J, Cheng C, Hao D, Yang S, Chen Y, Wang X, Kang C, Ji J, Man J, Agnihotri S, Wang Q, Lin F, Qian X, Mack SC, Hu Z, Li C, Taylor MD, Li Y, Zhang N, Rich JN, You Y, Wang X.
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00481-1. doi: 10.1016/j.ccell.2024.12.006. PMID: 39753140. Laboratory investigation˰ ˍ
RELATED ARTICLE
Kirschstein E, Gunderson AJ.
Plasma cell and cancer stem cell crosstalk in glioblastoma.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00482-3. doi: 10.1016/j.ccell.2024.12.007. PMID: 39753137. Comment˰ ˍ

Licón-Muñoz Y, Avalos V, Subramanian S, Granger B, Martinez F, García-Montaño LA, Varela S, Moore D, Perkins E, Kogan M, Berto S, Chohan MO, Bowers CA, Piccirillo SGM.
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.
Cell Rep. 2025 Jan 2;44(1):115149. doi: 10.1016/j.celrep.2024.115149. PMID: 39752252. Laboratory investigation. ˍ

Lim S, Clarke NH, Maloney SL, Sener UT, Caron SJ, Kizilbash SH, Campian JL, Neth BJ, Carabenciov ID, Uhm J, Ruff MW.
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04916-8. PMID: 39747716. Observational study˰ ˍ

Pełka K, Koczyk K, Koperski L, Dziedzic T, Nowak A, Królicki L, Kunert P, Kunikowska J.
Imply on diagnosis and early prognosis of preoperative [⁶⁸Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.
Sci Rep. 2025 Jan 2;15(1):214. doi: 10.1038/s41598-024-84036-5. PMID: 39747932. Interventional study. ˍ

Almeida ND, Rupp J, Gulzar B, Schrand TV, Madhugiri V, Fang M, Shekher R, Goulenko V, Goyal D, Prasad S, Milano MT, Prasad D.
Evaluating the impact of performance status in elderly patients with glioblastoma.
J Clin Neurosci. 2025 Jan 3;133:111028. doi: 10.1016/j.jocn.2024.111028. PMID: 39755030. Observational study. ˍ

Chen Z, Liu H, Yang A, Liao J, Wu Z, Chen J, Miao W.
68Ga-Pentixafor PET in Combination With MRI Improves the Differential Diagnosis of Glioblastoma and Primary Central Nervous System Lymphoma.
Clin Nucl Med. 2025 Jan 6. doi: 10.1097/RLU.0000000000005657. PMID: 39761437. Observational study˰ ˍ

Narsinh KH, Kumar K, Bankiewicz K, Martin AJ, Berger M, Clarke J, Taylor J, Bush NAO, Molinaro AM, Aghi M, Butowski N.
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04904-y. PMID: 39760796. Interventional study. ˍ

Suzuki M, Koga Y, Kawasaki T, Ueda T, Yamamoto S, Goto H, Kishimoto J, Ishida E, Todaka K, Sonoda KH, Oda Y, Koji Y, Sakai Y, Ohga S.
Access Program for Unapproved and Off-Label Drug Use in Pediatric BRAF V600E-Mutated Brain Tumors in Japan.
Pediatr Blood Cancer. 2025 Jan 6:e31510. doi: 10.1002/pbc.31510. PMID: 39762715. Interventional study. ˍ

Wu Y, Chen Z, Shi M, Qiu S, Zhang Y.
Nimotuzumab and bevacizumab combined with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma multiforme: a retrospective single-arm study.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04932-8. PMID: 39760795. Observational study˰ ˍ

Zhao XY, Yu JH, Wang YH, Liu YX, Xu L, Fu L, Yi N.
Lipomatous ependymoma with ZFTA: RELA fusion-positive: A case report.
World J Clin Cases. 2025 Jan 6;13(1):99746. doi: 10.12998/wjcc.v13.i1.99746. PMID: 39764539. Case report. ˍ

Dagar A, Ghosh A, Aashita, Kumar A, N YIK, Kamboj K, Sharma A, Raj J, Sharma D, Mallick S.
Survival and toxicity outcomes of hypofractionated conformal radiotherapy compared to conventionally fractionated radiotherapy in the treatment of diffuse intrinsic pontine gliomas.
Childs Nerv Syst. 2025 Jan 7;41(1):85. doi: 10.1007/s00381-024-06700-5. PMID: 39774994. Observational study˰ ˍ

Vitanza NA, Ronsley R, Choe M, Seidel K, Huang W, Rawlings-Rhea SD, Beam M, Steinmetzer L, Wilson AL, Brown C, Beebe A, Lindgren C, Gustafson JA, Wein A, Holtzclaw S, Hoeppner C, Goldstein HE, Browd SR, Hauptman JS, Lee A, Ojemann JG, Crotty EE, Leary SES, Perez FA, Wright JN, Alonso MM, Dun MD, Foster JB, Hurst D, Kong A, Thomsen A, Orentas RJ, Albert CM, Pinto N, Annesley C, Gardner RA, Ho O, Pattabhi S, Gust J, Wendler JP, Park JR, Jensen MC.
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.
Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03451-3. PMID: 39775044. Interventional study. ˍ

Sedlák V, Němý M, Májovský M, Bubeníková A, Nordin LE, Moravec T, Engelová J, Sila D, Konečná D, Belšan T, Westman E, Netuka D.
IDH Status in Brain Gliomas Can Be Predicted by the Spherical Mean MRI Technique.
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):121-128. doi: 10.3174/ajnr.A8432. PMID: 39779292. Observational study. ˍ

Xie J, Zhu Y, Yang Z, Yu Z, Yang M, Wang Q.
An integrative analysis reveals cancer risk associated with artificial sweeteners.
J Transl Med. 2025 Jan 8;23(1):32. doi: 10.1186/s12967-024-06047-0. PMID: 39780215. Observational study. ˍ

Seker S, Altay T, Uysal E, Cine HS, Yavuz AY, Avci I.
The correlation histopathological and conventional/advanced MRI techniques in glial tumors.
Cir Cir. 2025 Jan 9. doi: 10.24875/CIRU.23000648. PMID: 39787621. Observational study. ˍ

Shibuma S, On J, Natsumeda M, Koyama A, Takahashi H, Watanabe J, Mitobe M, Nakata S, Tanaka Y, Tsukamoto Y, Okada M, Yoshimura J, Tada M, Shimizu H, Oya S, Murai J, Okamoto K, Kawashima H, Kakita A, Oishi M.
Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.
Pediatr Blood Cancer. 2025 Jan 9:e31535. doi: 10.1002/pbc.31535. PMID: 39789738. Observational study˰ ˍ

Chen J, Shaw JM, Dhillon HM, Halkett GKB, McDougall E, Nowak AK, Campbell R; BRAINs Program Investigators.
Development of a brief screening measure of unmet supportive care needs (SCNS-P&C-6) in caregivers of people with high-grade glioma.
J Patient Rep Outcomes. 2025 Jan 10;9(1):6. doi: 10.1186/s41687-024-00835-4. PMID: 39792320. Observational study. ˍ

Kuroda H, Okita Y, Arisawa A, Utsugi R, Murakami K, Hirayama R, Kijima N, Arita H, Kinoshita M, Fujimoto Y, Nakamura H, Kagawa N, Tomiyama N, Kishima H.
Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastoma.
PLoS One. 2025 Jan 10;20(1):e0316168. doi: 10.1371/journal.pone.0316168. PMID: 39792964. Observational study. ˍ

Sim Y, McClelland AC, Choi K, Han K, Park YW, Ahn SS, Chang JH, Kim SH, Gardner S, Lee SK, Jain R.
A comprehensive multicenter analysis of clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma in adults.
J Neurosurg. 2025 Jan 10:1-12. doi: 10.3171/2024.8.JNS241180. PMID: 39793011. Observational study˰ ˍ

Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wißmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, Fankhauser L, Garofano L, Freudenberg A, Wagner J, Tanev DI, Ratliff M, Xie R, Kessler T, Hoffmann DC, Hai L, Dörflinger Y, Hoppe S, Yabo YA, Golebiewska A, Niclou SP, Sahm F, Lasorella A, Slowik M, Döring L, Iavarone A, Wick W, Kuner T, Winkler F.
Glioblastoma hijacks neuronal mechanisms for brain invasion.
Cell. 2022 Jul 31;185(16):2899-2917.e31. doi: 10.1016/j.cell.2022.06.054. PMID: 35914528. Laboratory investigation. ˍ

González ML, Ciervide R, Requejo OH, Luis ÁM, Rodriguez BÁ, Saugar ES, Iracheta LA, Chen X, Garcia-Aranda M, Zucca D, Valero J, Alonso R, Fernández- Letón P, Rubio C.
Reirradiation of gliomas with hypofractionated stereotactic radiotherapy: efficacy and tolerance analysis at a single center.
Rep Pract Oncol Radiother. 2024 Oct 15;29(5):566-578. doi: 10.5603/rpor.102820. PMID: 39759563. Observational study. ˍ

Dev ID, Puranik AD, Rangarajan V, Patra S, Purandare N, Sahu A, Choudhary A, Bhattacharya K, Gupta T, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Singh V, Sridhar E, Sahay A, Shah A, Ghosh S, Choudhury S, Shah S, Agrawal A.
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas.
Explor Target Antitumor Ther. 2024 Oct 31;5(6):1289-1296. doi: 10.37349/etat.2024.00276. PMID: 39759219. Observational study. ˍ

Xiao ZY, Sun YX, Xu DR, Ning XH, Wang Y, Zhang Y, Ma WB.
End-of-Life Inpatient Palliative Care for Glioblastoma Multiforme: Lessons Learned from One Case.
Chin Med Sci J. 2024 Nov 3;39(4):297-302. doi: 10.24920/004394. PMID: 39789933. Case report. ˍ

Panetta JC, Selvo NS, Mater DV, Stewart CF.
Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors.
Pharmaceutics. 2024 Nov 28;16(12):1528. doi: 10.3390/pharmaceutics16121528. PMID: 39771507. Interventional study. ˍ

Zhang JF, Mix MD, Shapiro A, Babu H.
Repeat GammaTile Brachytherapy in the Long-Term Management of Recurrent High-Grade Glioma: A Case Report.
Cureus. 2024 Dec 3;16(12):e75053. doi: 10.7759/cureus.75053. PMID: 39759633. Case report. ˍ

*Lyukmanova EN, Kirichenko AV, Medyanik IA, Yashin KS, Kirpichnikov MP, Bychkov ML.
Extracellular Vesicles from Plasma of Patients with Glioblastoma Promote Invasion of Glioblastoma Cells Even After Tumor Resection.
Biomedicines. 2024 Dec 13;12(12):2834. doi: 10.3390/biomedicines12122834. PMID: 39767739. Laboratory investigation. ˍ

Zhang X, Zheng Z, Guo X, Wang H, Gong L, Wang Y, Guo F, Ma W.
Risk Prediction and Management for Central Nervous System Infection After Resection for Gliomas-The 8-Year Experience from a Tertiary Medical Center.
J Clin Med. 2024 Dec 18;13(24):7733. doi: 10.3390/jcm13247733. PMID: 39768656. Observational study. ˍ

*Panotopoulos C, Athanasiou G, Stavropoulos S, Boutos N, Rao S, Panayotou G, Venkataramana NK, Ronquist G.
Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases.
Anticancer Res. 2024 Dec 30;45(1):201-207. doi: 10.21873/anticanres.17405. PMID: 39740841. Case report˰ ˍ

Su Y, Wang J, Guo J, Liu X, Yang X, Cheng R, Wang C, Xu C, He Y, Ji H.
Bi-exponential diffusion-weighted imaging for differentiating high-grade gliomas from solitary brain metastases: a VOI-based histogram analysis.
Sci Rep. 2024 Dec 30;14(1):31909. doi: 10.1038/s41598-024-83452-x. PMID: 39738411. Observational study. ˍ

Chen L, Wu M, Li Y, Tang L, Tang C, Huang L, Li T, Zhu L.
Assessment of MGMT and TERT Subtypes and Prognosis of Glioblastoma by Whole Tumor Apparent Diffusion Coefficient Histogram Analysis.
Brain Behav. 2024 Dec 31;15(1):e70175. doi: 10.1002/brb3.70175. PMID: 39739534. Observational study. ˍ

Chen Y, Yu W, Huang Y, Jiang Z, Deng J, Qi Y.
Causal Associations between Sleep Traits, Sleep Disorders, and Glioblastoma: A Two-Sample Bidirectional Mendelian Randomization Study.
J Neurophysiol. 2024 Dec 31. doi: 10.1152/jn.00338.2024. PMID: 39740798. Observational study˰ ˍ

Fotakopoulos G, Georgakopoulou VE, Spandidos DA, Angelopoulou E, Menis AA, Trakas N, Alexiou G, Voulgaris S.
Prognostic factors for first recurrence following meningioma surgery.
Med Int (Lond). 2024 Dec 31;5(2):14. doi: 10.3892/mi.2024.213. PMID: 39790708. Observational study. ˍ